Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma

NCT06934057 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Kidney Cancer
Renal Cell Cancer

Interventions

DRUG: Nivolumab
DRUG: Cabozantinib

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris

Collaborators

[object Object]